Last 12 months
Inside the activity.
2 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 27, 2023 Filed Jan 31, 2023 16:03 UTC |
Salkind GeneDirector
|
GrantNon-qualified Stock Options (right to buy) · Derivative | 30,000 | Not disclosed Strike: $1.60 | Not disclosed |
DisclosureSEC source: 0001683168-23-000434 · ownership.xml · derivative · entry 1 Salkind Gene · CIK 0001592481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F1 · security: On January 27, 2023, the reporting person received a grant of 30,000 stock options, as non-qualified options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2023, the next 25% vesting on 6/30/2023, the next 25% vesting on 9/30/23, and the final 25% vesting on 12/31/23. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 10:53 UTC |
Deschamps PhilippeDirector
|
GrantNon-qualified Stock Options (right to buy) · Derivative | 30,000 | Not disclosed Strike: $1.60 | Not disclosed |
DisclosureSEC source: 0001683168-23-000428 · ownership.xml · derivative · entry 1 Deschamps Philippe · CIK 0001638231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F1 · security: On January 27, 2023, the reporting person received a grant of 30,000 stock options, as non-qualified options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2023, the next 25% vesting on 6/30/2023, the next 25% vesting on 9/30/23, and the final 25% vesting on 12/31/23. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 16:09 UTC |
Yerace Daniel AlexanderDirector · VP of Operations
|
GrantIncentive Stock Options (right to buy) · Derivative | 200,000 | Not disclosed Strike: $1.60 | Not disclosed |
DisclosureSEC source: 0001683168-23-000438 · ownership.xml · derivative · entry 1 Yerace Daniel Alexander · CIK 0001846625 · Director · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires not disclosed F1 · security: On January 27, 2023, the reporting person received a grant of 200,000 incentive stock options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F3 · derivative.exercise_date: Options will vest over 4 years, with the first 25% vesting on 12/31/23, and the balance vesting in equal quarterly installments over the succeeding three years, with the final options vesting on 12/31/26. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 16:05 UTC |
Sheehy Christine EliseDirector · CFO and Secretary
|
GrantIncentive Stock Options (right to buy) · Derivative | 200,000 | Not disclosed Strike: $1.60 | Not disclosed |
DisclosureSEC source: 0001683168-23-000436 · ownership.xml · derivative · entry 1 Sheehy Christine Elise · CIK 0001846632 · Director · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires not disclosed F1 · security: On January 27, 2023, the reporting person received a grant of 200,000 incentive stock options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F3 · derivative.exercise_date: Options will vest over 4 years, with the first 25% vesting on 12/31/23, and the balance vesting in equal quarterly installments over the succeeding three years, with the final options vesting on 12/31/26. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 15:59 UTC |
Mehalick DavidDirector · CEO and President · 10% owner
|
GrantIncentive Stock Options (right to buy) · Derivative | 250,000 | Not disclosed Strike: $1.76 | Not disclosed |
DisclosureSEC source: 0001683168-23-000432 · ownership.xml · derivative · entry 2 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires not disclosed F2 · security: On January 27, 2023, the reporting person received a grant of 250,000 incentive stock options, under the 2022 equity incentive plan. F6 · derivative.exercise_price: The exercise price is equal to 110% of the FMV of the shares on the day of grant. F6 · price: The exercise price is equal to 110% of the FMV of the shares on the day of grant. F4 · derivative.exercise_date: Options will vest over 4 years, with the first 25% vesting on 12/31/23, and the balance vesting in equal quarterly installments over the succeeding three years, with the final options vesting on 12/31/26. F8 · derivative.expiration_date: Expiration date is five years from the day of grant, as the reporting person is a 10% owner and the options are incentive stock options. F10 · balance_after: Following the exercise of options under both reported transactions, the reporting person will have a total of 625,000 derivative securities beneficially owned. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 15:59 UTC |
Mehalick DavidDirector · CEO and President · 10% owner
|
GrantNon-qualified Stock Options (right to buy) · Derivative | 375,000 | Not disclosed Strike: $1.60 | Not disclosed |
DisclosureSEC source: 0001683168-23-000432 · ownership.xml · derivative · entry 1 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,000 Underlying: Common Stock · 375,000 shares Expires not disclosed F1 · security: On January 27, 2023, the reporting person received a grant of 375,000 stock options, as non-qualified options, under the 2022 equity incentive plan. F5 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F5 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F3 · derivative.exercise_date: Options will vest over 4 years, with the first 25% vesting on 12/31/23, and the balance vesting in equal quarterly installments over the succeeding three years, with the final options vesting on 12/31/26. F7 · derivative.expiration_date: Expiration date is ten years from the day of grant F9 · balance_after: Following the exercise of options under both reported transactions, the reporting person will have a total of 625,000 derivative securities beneficially owned. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 15:55 UTC |
DeSilva TaraDirector
|
GrantNon-qualified Stock Options (right to buy) · Derivative | 30,000 | Not disclosed Strike: $1.60 | Not disclosed |
DisclosureSEC source: 0001683168-23-000430 · ownership.xml · derivative · entry 1 DeSilva Tara · CIK 0001952535 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F1 · security: On January 27, 2023, the reporting person received a grant of 30,000 stock options, as non-qualified options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2023, the next 25% vesting on 6/30/2023, the next 25% vesting on 9/30/23, and the final 25% vesting on 12/31/23. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 15:51 UTC |
Cochran Christopher P.Director
|
GrantNon-qualified Stock Options (right to buy) · Derivative | 30,000 | Not disclosed Strike: $1.60 | Not disclosed |
DisclosureSEC source: 0001683168-23-000426 · ownership.xml · derivative · entry 1 Cochran Christopher P. · CIK 0001951916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F1 · security: On January 27, 2023, the reporting person received a grant of 30,000 stock options, as non-qualified options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 4/27/2023, the next 25% vesting on 7/27/2023, the next 25% vesting on 10/27/23, and the final 25% vesting on 1/27/24. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 15:50 UTC |
Calise ChrisDirector
|
GrantNon-qualified Stock Options (right to buy) · Derivative | 30,000 | Not disclosed Strike: $1.60 | Not disclosed |
DisclosureSEC source: 0001683168-23-000424 · ownership.xml · derivative · entry 1 Calise Chris · CIK 0001824769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F1 · security: On January 27, 2023, the reporting person received a grant of 30,000 stock options, as non-qualified options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2023, the next 25% vesting on 6/30/2023, the next 25% vesting on 9/30/23, and the final 25% vesting on 12/31/23. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| October 28, 2022 Filed Nov 2, 2022 01:30 UTC |
Bull Horn Holdings Sponsor LLC10% owner
Calise ChrisDirector · 10% owner
Striar Robert10% owner
|
GrantWarrant · Derivative | 3,000,000 | $1.00 Strike: $11.50 | $3,000,000.00 |
DisclosureSEC source: 0001213900-22-068387 · ownership.xml · derivative · entry 1 Bull Horn Holdings Sponsor LLC · CIK 0001759065 · 10% owner Calise Chris · CIK 0001824769 · Director · 10% owner Striar Robert · CIK 0001824965 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000,000 Underlying: Common Stock · 3,000,000 shares Expires 2027-10-28 F1 · date: On October 28, 2022, Bull Horn Holdings Corp. ("Bull Horn") completed its initial business combination with Coeptis Therapeutics, Inc., a Delaware corporation ("Coeptis"), and changed its name to Coeptis Therapeutics Holdings, Inc., pursuant to that certain Agreement and Plan of Merger, dated as of April 18, 2022. F2 · kind: Bull Horn Holdings Sponsor LLC (the "Sponsor") acquired these warrants for a purchase price of $1.00 per warrant in connection with the initial public offering of Bull Horn. The warrants could only become eligible for exercise upon consummation of Bull Horn's initial business combination. Since the exercise of the warrants was contingent upon the closing of the business combination, these warrants were not reported at the time of acquisition. The acquisition is being reported now in connection with the consummation of Bull Horn's initial business combination with Coeptis. F3 · ownership.direct: The Sponsor is the record holder of the warrants reported herein. Christopher Calise and Robert Striar are the managing members of the Sponsor and have voting and dispositive power over the warrants held by the Sponsor. Each of Mr. Calise and Mr. Striar disclaims any beneficial ownership of the reported warrants other than to the extent of any pecuniary interest he may have therein. Read SEC document |
| May 04, 2022 Filed May 6, 2022 18:19 UTC |
Harraden Circle Investments, LLC10% owner
Harraden Circle Investors GP, LLC10% owner
Harraden Circle Investors GP, LP10% owner
Harraden Circle Investors, LP10% owner
Fortmiller Frederick Vincent Jr.10% owner
|
SaleOrdinary Shares | 85,305 | $10.11 | $862,433.55 |
DisclosureSEC source: 0001567619-22-009708 · doc1.xml · nonDerivative · entry 1 Harraden Circle Investments, LLC · CIK 0001910592 · 10% owner Harraden Circle Investors GP, LLC · CIK 0001927546 · 10% owner Harraden Circle Investors GP, LP · CIK 0001927544 · 10% owner Harraden Circle Investors, LP · CIK 0001700249 · 10% owner Fortmiller Frederick Vincent Jr. · CIK 0001927576 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 429,131 F1 · ownership.direct: These ordinary shares of the Issuer ("Shares") are directly owned by Harraden Circle Investors, LP ("Harraden Fund"). Harraden Circle Investors GP, LP ("Harraden GP") is the general partner to Harraden Fund, and Harraden Circle Investors GP, LLC ("Harraden LLC") is the general partner of Harraden GP. Harraden Circle Investments, LLC ("Harraden Adviser") serves as investment manager to Harraden Fund. Frederick V. Fortmiller, Jr. ("Mr. Fortmiller") is the managing member of each of Harraden LLC and Harraden Adviser. Each of Harraden GP, Harraden LLC, Harraden Adviser, and Mr. Fortmiller disclaims beneficial ownership of the Shares reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. F1 · ownership.nature: These ordinary shares of the Issuer ("Shares") are directly owned by Harraden Circle Investors, LP ("Harraden Fund"). Harraden Circle Investors GP, LP ("Harraden GP") is the general partner to Harraden Fund, and Harraden Circle Investors GP, LLC ("Harraden LLC") is the general partner of Harraden GP. Harraden Circle Investments, LLC ("Harraden Adviser") serves as investment manager to Harraden Fund. Frederick V. Fortmiller, Jr. ("Mr. Fortmiller") is the managing member of each of Harraden LLC and Harraden Adviser. Each of Harraden GP, Harraden LLC, Harraden Adviser, and Mr. Fortmiller disclaims beneficial ownership of the Shares reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| May 26, 2021 Filed May 26, 2021 21:41 UTC |
GLAZER CAPITAL, LLC10% owner
GLAZER PAUL J10% owner
|
SaleOrdinary Shares | 6,118 | $9.85 | $60,262.30 |
DisclosureSEC source: 0001076809-21-000196 · bhse20210526.xml · nonDerivative · entry 2 GLAZER CAPITAL, LLC · CIK 0001076809 · 10% owner GLAZER PAUL J · CIK 0001133985 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote 1. Disclosed balance after: 964,422 F1 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Glazer Capital, LLC, a Delaware limited liability company, serves as investment manager. Mr. Paul J. Glazer serves as the Managing Member of Glazer Capital, LLC. Each of Glazer Capital, LLC and Mr. Paul J. Glazer disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:41 UTC |
GLAZER CAPITAL, LLC10% owner
GLAZER PAUL J10% owner
|
SaleOrdinary Shares | 50,000 | $9.85 | $492,500.00 |
DisclosureSEC source: 0001076809-21-000196 · bhse20210526.xml · nonDerivative · entry 1 GLAZER CAPITAL, LLC · CIK 0001076809 · 10% owner GLAZER PAUL J · CIK 0001133985 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote 1. Disclosed balance after: 1,016,500 F1 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Glazer Capital, LLC, a Delaware limited liability company, serves as investment manager. Mr. Paul J. Glazer serves as the Managing Member of Glazer Capital, LLC. Each of Glazer Capital, LLC and Mr. Paul J. Glazer disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| December 14, 2020 Filed Dec 14, 2020 22:11 UTC |
Bull Horn Holdings Sponsor LLC10% owner
|
OtherOrdinary Shares | 281,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-042569 · ownership.xml · nonDerivative · entry 1 Bull Horn Holdings Sponsor LLC · CIK 0001759065 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875,000 F2 · kind: Messrs. Robert Striar and Christopher Calise are the managing members of the reporting person and have voting and investment discretion with respect to the securities held by the reporting person. As such, they may be deemed to share beneficial ownership of the ordinary shares held directly by the reporting person. F3 · shares: As contemplated in connection with the initial public offering of the issuer, 281,250 ordinary shares of the issuer were returned by the reporting person to the issuer for no consideration and cancelled because the underwriters' over-allotment option was not exercised. F1 · balance_after: These ordinary shares represent ordinary shares held by the reporting person acquired pursuant to a subscription agreement by and between the reporting person and the issuer. Read SEC document |
| December 14, 2020 Filed Dec 14, 2020 22:10 UTC |
Striar RobertDirector · Chief Executive Officer · 10% owner
|
OtherOrdinary Shares | 281,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-042565 · ownership.xml · nonDerivative · entry 1 Striar Robert · CIK 0001824965 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Bull Horn Holdings Sponsor LLC Disclosed balance after: 1,875,000 F2 · kind: Mr. Robert Striar is a managing member of the Sponsor and has voting and investment discretion with respect to the securities held by the Sponsor. As such, he may be deemed to share beneficial ownership of the ordinary shares held directly by the Sponsor. F3 · shares: As contemplated in connection with the initial public offering of the issuer, 281,250 ordinary shares of the issuer were returned by the Sponsor to the issuer for no consideration and cancelled because the underwriters' over-allotment option was not exercised. F1 · balance_after: These ordinary shares represent ordinary shares held by Bull Horn Holdings Sponsor LLC (the "Sponsor") acquired pursuant to a subscription agreement by and between the Sponsor and the issuer. F2 · ownership.nature: Mr. Robert Striar is a managing member of the Sponsor and has voting and investment discretion with respect to the securities held by the Sponsor. As such, he may be deemed to share beneficial ownership of the ordinary shares held directly by the Sponsor. Read SEC document |
| December 14, 2020 Filed Dec 14, 2020 22:08 UTC |
Calise ChrisDirector · Chief Financial Officer · 10% owner
|
OtherOrdinary Shares | 281,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-042561 · ownership.xml · nonDerivative · entry 1 Calise Chris · CIK 0001824769 · Director · Chief Financial Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Bull Horn Holdings Sponsor LLC Disclosed balance after: 1,875,000 F2 · kind: Mr. Christopher Calise is a managing member of the Sponsor and has voting and investment discretion with respect to the securities held by the Sponsor. As such, he may be deemed to share beneficial ownership of the ordinary shares held directly by the Sponsor. F3 · shares: As contemplated in connection with the initial public offering of the issuer, 281,250 ordinary shares of the issuer were returned by the Sponsor to the issuer for no consideration and cancelled because the underwriters' over-allotment option was not exercised. F1 · balance_after: These ordinary shares represent ordinary shares held by Bull Horn Holdings Sponsor LLC (the "Sponsor") acquired pursuant to a subscription agreement by and between the Sponsor and the issuer. F2 · ownership.nature: Mr. Christopher Calise is a managing member of the Sponsor and has voting and investment discretion with respect to the securities held by the Sponsor. As such, he may be deemed to share beneficial ownership of the ordinary shares held directly by the Sponsor. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.